PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)

Corinne Faivre-Finn; Tiana Kordbacheh; C Chan; A Bossons; K Franks; F McDonald; M Forster; r Mendes; S Quezada; Simon Dovedi; c Ralph; S Popat; K Harrington; A Melcher; A Popple; Timothy Illidge

PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)

Corinne Faivre-Finn, Tiana Kordbacheh, C Chan, A Bossons, K Franks, F McDonald, M Forster, r Mendes, S Quezada, Simon Dovedi, c Ralph, S Popat, K Harrington, A Melcher, A Popple, Timothy Illidge

Division of Cancer Sciences (L5)

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Pages	S75(164)
Publication status	Published - Jan 2017

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Faivre-Finn, C., Kordbacheh, T., Chan, C., Bossons, A., Franks, K., McDonald, F., Forster, M., Mendes, R., Quezada, S., Dovedi, S., Ralph, C., Popat, S., Harrington, K., Melcher, A., Popple, A., & Illidge, T. (2017). PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC). S75(164).

@conference{a2b56f6f716a478e8a3b1b9081f4222e,

title = "PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)",

author = "Corinne Faivre-Finn and Tiana Kordbacheh and C Chan and A Bossons and K Franks and F McDonald and M Forster and r Mendes and S Quezada and Simon Dovedi and c Ralph and S Popat and K Harrington and A Melcher and A Popple and Timothy Illidge",

year = "2017",

month = jan,

language = "English",

pages = "S75(164)",

}

Faivre-Finn, C , Kordbacheh, T, Chan, C, Bossons, A, Franks, K, McDonald, F, Forster, M, Mendes, R, Quezada, S, Dovedi, S, Ralph, C, Popat, S, Harrington, K, Melcher, A, Popple, A & Illidge, T 2017, 'PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)', pp. S75(164).

TY - CONF

T1 - PARIS: A phase I study of pembrolizumab anti-PD-1 monoclonal antibody in combination with radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC)

AU - Faivre-Finn, Corinne

AU - Kordbacheh, Tiana

AU - Chan, C

AU - Bossons, A

AU - Franks, K

AU - McDonald, F

AU - Forster, M

AU - Mendes, r

AU - Quezada, S

AU - Dovedi, Simon

AU - Ralph, c

AU - Popat, S

AU - Harrington, K

AU - Melcher, A

AU - Popple, A

AU - Illidge, Timothy

PY - 2017/1

Y1 - 2017/1

M3 - Abstract

SP - S75(164)

ER -